In Brief: Chiron Vaccines
Executive Summary
Chiron Vaccines: Magnus Lundberg to president, replacing Dino Dina who has resigned from the company. Lundberg, 40, who is president of Chiron Therapeutics, joined Chiron from Pharmacia & Upjohn in April 1996, where he was head of metabolic diseases. "Dino, whose background is in research and business strategy, elected to step aside in favor of more experienced commercial management," the company said...